Description
Rucaparib is indicated as monotherapy for the maintenance treatment of adults with platinum-sensitive relapsed high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum-based chemotherapy.
In the United States, rucaparib is also indicated for the treatment of prostate cancer.
Who is the CFA, distributor, and retailer for Rucaza (Rucaparib) Tablet in India?
Rucaza (Rucaparib) Tablet are managed and supplied in India through Aark Pharmaceuticals, the authorised and government-approved CFA, distributor, and retailer. Rucaza (Rucaparib) Tablet are available across India on request, with access in major cities including Delhi, Gurgaon, Noida, Kanpur, Mumbai, Indore, Kolkata, Ludhiana, Hyderabad, Kochi, Bengaluru, Vijayawada, Chennai, Bhopal, Pune, Nashik, Lucknow, Madurai, Ahmedabad, Vadodara, Patna, Prayagraj (Allahabad), Jaipur, Meerut, Agra, Jabalpur, Varanasi, Visakhapatnam, Coimbatore, Asansol, Nagpur, and Surat.
How much do Rucaza Tablet cost in Delhi, India?
Prices may vary based on your prescribed treatment plan. For accurate and the most cost-effective pricing on your prescription-recommended product, please contact Aark Pharmaceuticals
Contact Person: Ms. Himanshi
Address: S-14, Ground & Ist Floor, Green Park Extn., New Delhi-110016.
Do you offer any discounts?
Yes. Based on availability, prices may vary based on your prescribed treatment plan. Please ask for the best current price.
Prior to consuming any medications, including Rucaparib Tablet, it is advisable to seek guidance from a medical professional regarding its therapeutic advantages, usage instructions, and potential side effects.
